Malignant mesothelioma is a universally lethal cancer that is increasing in incidence
worldwide. There is a dearth of effective therapies, with only one treatment (pemetrexed and …

… Aerts has received honoraria for service on the speakers' bureau and is a consultant/advisory
board member of Roche. No potential conflicts of interest were disclosed by the other …

Background Patients with advanced squamous-cell non–small-cell lung cancer (NSCLC)
who have disease progression during or after first-line chemotherapy have limited treatment …

The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace inundating
medical facilities and creating substantial challenges globally. The risk of severe acute …

Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …

PD-1/PD-L1-checkpoint blockade therapy is generally thought to relieve tumor cell-mediated
suppression in the tumor microenvironment but PD-L1 is also expressed on non-tumor …

Introduction Final overall survival (OS) analyses are presented for EGFR mutations and liver
or brain metastases subgroups in the phase 3 IMpower150 study (NCT02366143) …

Rationale: The NELSON (Nederlands Leuvens Longkanker Screenings Onderzoek) trial is,
with 15,822 participants, the largest European lung cancer computer tomography screening …

Background The randomized, phase III AVAPERL trial evaluated the safety and efficacy of
bevacizumab maintenance with or without pemetrexed in nonsquamous nonsmall-cell lung …

Rationale: We previously demonstrated that dendritic cell-based immunotherapy induced
protective antitumor immunity with a prolonged survival rate in mice. However, the clinical …